相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse
Randi-Michelle Cowin et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins
M. D'Eletto et al.
CELL DEATH AND DIFFERENTIATION (2012)
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease
Ashish Kumar et al.
EXPERIMENTAL NEUROLOGY (2012)
Discovery and Structure-Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington's Disease
Michael E. Prime et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington's Disease: zQ175
Liliana B. Menalled et al.
PLOS ONE (2012)
Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
Taneli Heikkinen et al.
PLOS ONE (2012)
Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease
Lise Munsie et al.
HUMAN MOLECULAR GENETICS (2011)
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington's disease
Stephen J. McConoughey et al.
EMBO MOLECULAR MEDICINE (2010)
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
Kirupa Sathasivam et al.
HUMAN MOLECULAR GENETICS (2010)
Responses to Environmental Enrichment Differ with Sex and Genotype in a Transgenic Mouse Model of Huntington's Disease
Nigel I. Wood et al.
PLOS ONE (2010)
A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors
Sabine Schaertl et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice
A. Jennifer Morton et al.
NEUROBIOLOGY OF DISEASE (2009)
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled et al.
NEUROBIOLOGY OF DISEASE (2009)
CAG repeat lengths >= 335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse
I. Dragatsis et al.
NEUROBIOLOGY OF DISEASE (2009)
Increased levels of γ-glutamylamines in Huntington disease CSF
Thomas M. Jeitner et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Transcriptional signatures in Huntington's disease
Jang-Ho J. Cha
PROGRESS IN NEUROBIOLOGY (2007)
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Tissue transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes
Pier Giorgio Mastroberardino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase
Craig D. C. Bailey et al.
NEUROBIOLOGY OF AGING (2006)
Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms
CDC Bailey et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A novel function of tissue-type transglutaminase: protein disulphide isomerase
G Hasegawa et al.
BIOCHEMICAL JOURNAL (2003)
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease
P Mastroberardino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
MV Karpuj et al.
NATURE MEDICINE (2002)
Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients
K Sathasivam et al.
HUMAN MOLECULAR GENETICS (2001)
Targeted inactivation of Gh/tissue transglutaminase II
N Nanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tissue transglutaminase does not contribute to the formation of mutant Huntingtin aggregates
WJ Chun et al.
JOURNAL OF CELL BIOLOGY (2001)
Role of tissue transglutaminase in celiac disease
O Molberg et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)
分享论文
